SCSuzanne L. Cassel

Suzanne L. Cassel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Suzanne L. Cassel has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Fayyaz S. Sutterwala

    Inflammation Program, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA

    5 shared publications
  • John R. Janczy

    Inflammation Program, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America

    3 shared publications
  • Alicia K. Olivier

    Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America

    2 shared publications
  • Ceren Ciraci

    Inflammation Program, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America

    2 shared publications
  • Fayyaz S. Sutterwala

    Inflammation Program, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America

    2 shared publications
  • Jeffrey J. Sadler

    Inflammation Program, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America

    2 shared publications

Latest Publications

  • Open Access

    NLRC4 suppresses melanoma tumor progression independently of inflammasome activation

    by Ann M. Janowski, Oscar R. Colegio, Emma E. Hornick, Jennifer M. McNiff, Matthew D. Martin, Vladimir P. Badovinac, Lyse A. Norian, Weizhou Zhang, Suzanne L. Cassel, Fayyaz S. Sutterwala

    Members of the NLR family can assemble inflammasome complexes with the adaptor protein ASC and caspase-1 that result in the activation of caspase-1 and the release of IL-1β and IL-18. Although the NLRC4 inflammasome is known to have a protective role in tumorigenesis, there is an increased appreciation for the inflammasome-independent actions of NLRC4. Here, we utilized a syngeneic subcutaneous murine model of B16F10 melanoma to explore the role of NLRC4 in tumor suppression. We found that NLRC4-deficient mice exhibited enhanced tumor growth that was independent of the inflammasome components ASC and caspase-1. Nlrc4 expression was critical for cytokine and chemokine production in tumor-associated macrophages and was necessary for the generation of protective IFN-γ–producing CD4+ and CD8+ T cells. Tumor progression was diminished when WT or caspase-1–deficient, but not NLRC4-deficient, macrophages were coinjected with B16F10 tumor cells in NLRC4-deficient mice. Finally, examination of human primary melanomas revealed the extensive presence of NLRC4+ tumor-associated macrophages. In contrast, there was a paucity of NLRC4+ tumor-associated macrophages observed in human metastatic melanoma, supporting the concept that NLRC4 expression controls tumor growth. These results reveal a critical role for NLRC4 in suppressing tumor growth in an inflammasome-independent manner.


  • Open Access

    Immune Complexes Indirectly Suppress the Generation of Th17 Responses In Vivo

    by Ceren Ciraci, John R. Janczy, Nidhi Jain, Stefanie Haasken, Cyntia Pecli e Silva, Claudia F. Benjamim, Jeffrey J. Sadler, Alicia K. Olivier, Yoichiro Iwakura, Dmitry M. Shayakhmetov, et al.

    The precise context in which the innate immune system is activated plays a pivotal role in the subsequent instruction of CD4+ T helper (Th) cell responses. Th1 responses are downregulated when antigen is encountered in the presence of antigen-IgG immune complexes. To assess if Th17 responses to antigen are subject to similar influences in the presence of immune complexes we utilized an inflammatory airway disease model in which immunization of mice with Complete Freund’s Adjuvant (CFA) and ovalbumin (Ova) induces a powerful Ova-specific Th1 and Th17 response. Here we show that modification of that immunization with CFA to include IgG-Ova immune complexes results in the suppression of CFA-induced Th17 responses and a concurrent enhancement of Ova-specific Th2 responses. Furthermore, we show the mechanism by which these immune complexes suppress Th17 responses is through the enhancement of IL-10 production. In addition, the generation of Th17 responses following immunization with CFA and Ova were dependent on IL-1α but independent of NLRP3 inflammasome activation. Together these data represent a novel mechanism by which the generation of Th17 responses is regulated.


  • Top Cited Papers

    Mechanism of NLRP3 inflammasome activation

    by Fayyaz S. Sutterwala, Stefanie Haasken, Suzanne L. Cassel

    Inflammasomes continue to generate interest in an increasing number of disciplines owing to their unique ability to integrate a myriad of signals from pathogen‐ and damage‐associated molecular patterns into a proinflammatory response. This potent caspase‐1–dependent process is capable of activating the innate immune system, initiating pyroptosis (an inflammatory form of programmed cell death), and shaping adaptive immunity. The NLRP3 inflammasome is the most thoroughly studied of the inflammasome complexes that have been described thus far, perhaps owing to its disparate assortment of agonists. This review highlights our current understanding of the mechanisms of both priming and activation of the NLRP3 inflammasome.


  • Top Cited Papers

    Mitochondrial Cardiolipin Is Required for Nlrp3 Inflammasome Activation

    by Shankar S. Iyer, Qiong He, John R. Janczy, Eric I. Elliott, Zhenyu Zhong, Alicia K. Olivier, Jeffrey J. Sadler, Vickie Knepper-Adrian, Renzhi Han, Liang Qiao, et al.


  • Control of innate and adaptive immunity by the inflammasome

    by Ceren Ciraci, John R. Janczy, Fayyaz S. Sutterwala, Suzanne L. Cassel


  • Open Access

    Tim‐1 regulates Th2 responses in an airway hypersensitivity model

    by Miranda L. Curtiss, Jacob V. Gorman, Thomas R. Businga, Geri Traver, Melody Singh, David K. Meyerholz, Joel N. Kline, Andrew J. Murphy, David M. Valenzuela, John D. Colgan, et al.

    T‐cell immunoglobulin mucin‐1 (Tim‐1) is a transmembrane protein postulated to be a key regulator of Th2‐type immune responses. This hypothesis is based in part upon genetic studies associating Tim‐1 polymorphisms in mice with a bias toward airway hyperrespon‐siveness (AHR) and the development of Th2‐type CD4+ T cells. Tim‐1 expressed by Th2 CD4+ T cells has been proposed to function as a co‐stimulatory molecule. Tim‐1 is also expressed by B cells, macrophages, and dendritic cells, but its role in responses by these cell types has not been firmly established. Here, we generated Tim‐1‐deficient mice to determine the role of Tim‐1 in a murine model of allergic airway disease that depends on the development and function of Th2 effector cells and results in the generation of AHR. We found antigen‐driven recruitment of inflammatory cells into airways is increased in Tim‐1‐deficient mice relative to WT mice. In addition, we observed increased antigen‐specific cytokine production by splenocytes from antigen‐sensitized Tim‐1‐deficient mice relative to those from controls. These data support the conclusion that Tim‐1 functions in pathways that suppress recruitment of inflammatory cells into the airways and the generation or activity of CD4+ T cells.


  • Inflammasome-Mediated Autoinflammatory Disorders

    by Shruti P. Wilson, Suzanne L. Cassel

    The nucleotide-binding domain leucine-rich repeat containing (NLR) family of receptors are members of the innate immune system, and have a critical role in host defense. These molecules are key to driving inflammatory responses to abnormal cellular conditions. Many NLRs serve this role on activation by forming a multiprotein complex called an inflammasome. The inflammasome drives the processing and release of cytokines, such as the proinflammatory cytokines interleukin (IL)-1β and IL-18. Recently, the important function of NLR molecules in autoinflammatory disorders has been recognized, in part through the identification of the role of IL-1β in the pathogenesis of several autoinflammatory diseases. Cryopyrin-associated periodic syndromes were the first autoinflammatory disorders found to be directly mediated by dysfunctional inflammasome activation. This finding has subsequently led to studies in both murine models and humans that have revealed several other inflammatory conditions associated with activation of NLR-containing inflammasomes. Understanding the molecular pathophysiology of these autoinflammatory disorders has further guided the successful development of targeted therapy against IL-1. In this review, we provide an overview of the inflammasomes and describe the important role they play in the development and manifestation of autoinflammatory diseases.


  • Open Access

    Sterile inflammatory responses mediated by the NLRP3 inflammasome

    by Suzanne L. Cassel, Fayyaz S. Sutterwala

    Through pattern recognition receptors the innate immune system detects disruption of the normal function of the organism and initiates responses directed at correcting these derangements. Cellular damage from microbial or non‐microbial insults causes the activation of nucleotide‐binding domain leucine‐rich repeat containing receptors in multiprotein complexes called inflammasomes. Here we discuss the role of the NLRP3 inflammasome in the recognition of cellular damage and the initiation of sterile inflammatory responses.


  • The NLRP3 inflammasome: A sensor of immune danger signals

    by Suzanne L. Cassel, Sophie Joly, Fayyaz S. Sutterwala